## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `article_bundle` — **LLM article bundle** Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. - **article slug:** `tesamorelin-gut` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system. - **read:** https://miscsubjects.com/api/articles/tesamorelin-gut/bundle?format=markdown ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-gut/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tesamorelin-gut/topology - **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/tesamorelin-gut/voxels - **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tesamorelin-gut/prompts - **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node. - **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/tesamorelin-gut/voxels - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.* --- # miscsubjects article bundle > Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest. ## MASTHEAD - **identity:** `tesamorelin-gut` v2 · content_hash `6badeb54178a1366…` · thread_head genesis · 18 DIVs - **thesis (c1):** Two Phase 3 trials in 816 HIV patients showed 15-18% visceral adipose tissue reduction after 26 weeks of 2 mg daily tesamorelin. - c2 [human/active] Visceral fat reduction reversed when treatment stopped in extension phases. - c3 [human/active] A 48-patient randomized trial found modest liver fat reduction with tesamorelin alongside visceral fat loss. - c4 [human/active] No published human trials examine tesamorelin for direct gut barrier, microbiome, or non-HIV abdominal conditions. - c5 [anecdotal/active] Reddit users report targeted deep belly fat loss with quick return after stopping. - c6 [anecdotal/active] X posts note FDA approval history and reversal of visceral fat loss upon discontinuation. - **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes - **standing objections:** 0 open → https://miscsubjects.com/api/articles/tesamorelin-gut/discourse - **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key - **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/tesamorelin-gut/discourse · https://miscsubjects.com/api/protocol ## Article - **slug:** `tesamorelin-gut` - **title:** Tesamorelin and Visceral Abdominal Fat: What Human Trials Show on GH Axis Effects - **url:** https://miscsubjects.com/a/tesamorelin-gut - **register:** source_ledger - **updated:** 2026-07-17T02:42:23.104Z - **tags:** peptide, matrix ## Body ## What's breaking down Excess visceral fat accumulates around abdominal organs, including areas near the gut. This layer sits deep and can press on digestive structures. Growth hormone pulses often decline with age or certain conditions, shifting fat storage toward visceral deposits rather than subcutaneous. If visceral fat builds faster than the body clears it, abdominal girth increases and metabolic stress on nearby tissues rises. Tesamorelin targets the GH axis to address this specific deposition pattern. ## Why Tesamorelin might help you 1. Tesamorelin acts as a growth hormone-releasing hormone analog. It stimulates the pituitary to release more of your own growth hormone in pulses. 2. Higher pulsatile GH increases IGF-1 and shifts fat metabolism away from visceral storage. 3. Therefore for you: If visceral fat around abdominal organs forms part of your picture, the compound is discussed because it supports selective reduction in that compartment rather than blanket suppression of appetite or inflammation. 4. Reduced visceral fat lowers mechanical pressure on abdominal contents and improves lipid markers in studied populations. 5. The effect occurs without major loss of subcutaneous fat or lean mass in the key trials. ## How these fit together Single-compound focus. Tesamorelin maps directly to the GH axis and visceral fat layer. No sibling peptides are in scope, so the discussion stays on this pathway alone. ## What the evidence actually shows Human data come from Phase 3 randomized, double-blind, placebo-controlled trials in HIV patients with excess abdominal fat. Two trials totaling 816 participants showed 15-18% reduction in visceral adipose tissue after 26 weeks at 2 mg daily subcutaneous. Visceral fat dropped while subcutaneous fat stayed stable. Triglycerides fell and body image scores improved. A separate 48-patient trial found modest liver fat reduction alongside visceral fat loss. Effects reversed when treatment stopped. No large trials exist in non-HIV populations for gut-specific outcomes. Animal or mechanistic data on intestinal permeability or microbiome are absent from published sources. ## What scientists say Researchers note selective visceral fat reduction without worsening glucose tolerance in the studied groups. They highlight preservation of lean mass and improvement in waist circumference. Long-term extension data up to 52 weeks show maintenance of the reduction while on treatment. Scientists emphasize the compound is approved only for HIV-associated lipodystrophy and call for further studies outside that population. ## What people say on Reddit Users describe targeted deep belly fat loss that does not affect love handles much. Some report the lost visceral fat returns quickly after stopping. Others combine it with training and note better waist measurements. Comments stress that diet and exercise drive overall results while the compound helps the stubborn visceral compartment. ## What people say on X Posts highlight preservation of muscle during fat loss and note the FDA approval history for visceral reduction. Several users mention measuring visceral fat before starting and watching for injection-site reactions or fluid retention. One post references reversal upon discontinuation, aligning with trial observations. ## What we do not know Direct effects on gut barrier function, microbiome composition, or non-visceral gut conditions remain unstudied in humans. No trials examine Tesamorelin for inflammatory bowel disease, leaky gut markers, or general population abdominal fat outside HIV. Long-term data beyond one year in healthy individuals are limited. ## Safety and limits Common reports include injection-site reactions, joint discomfort, and tingling. Glucose monitoring is advised because transient rises appeared early in some participants. The compound is prescription-only for its approved indication. Effects on visceral fat reverse after stopping in the available studies. Individual responses vary and no compound replaces foundational nutrition or activity. ## Claims (6) - **c4** [human w=0.8] No published human trials examine tesamorelin for direct gut barrier, microbiome, or non-HIV abdominal conditions. - who_claims: grok/grok-4.3 - **c1** [human w=0.8] Two Phase 3 trials in 816 HIV patients showed 15-18% visceral adipose tissue reduction after 26 weeks of 2 mg daily tesamorelin. - who_claims: grok/grok-4.3 - sources: s1 - **c2** [human w=0.8] Visceral fat reduction reversed when treatment stopped in extension phases. - who_claims: grok/grok-4.3 - sources: s1 - **c3** [human w=0.8] A 48-patient randomized trial found modest liver fat reduction with tesamorelin alongside visceral fat loss. - who_claims: grok/grok-4.3 - sources: s2 - **c5** [anecdotal w=0.3] Reddit users report targeted deep belly fat loss with quick return after stopping. - who_claims: grok/grok-4.3 - sources: s3 - **c6** [anecdotal w=0.3] X posts note FDA approval history and reversal of visceral fat loss upon discontinuation. - who_claims: grok/grok-4.3 - sources: s4 ## Voxel graph (6 atoms · 11 edges) - full graph: https://miscsubjects.com/api/articles/tesamorelin-gut/voxels ## Article constitution - full: https://miscsubjects.com/api/articles/constitution ## Source ledger (4) - chain valid: yes · head: `bfa509652e40bf54` ### s1 · pubmed · ok - title: Effects of tesamorelin on visceral fat in HIV patients - url: https://pubmed.ncbi.nlm.nih.gov/20101189/ - summary: Pooled Phase 3 data showing visceral fat reduction and reversal on discontinuation. - quote: VAT decreased by -10.9% in the tesamorelin group vs. -0.6% in the placebo group... VAT was reduced by approximately 18% in patients continuing tesamorelin for 12 months. - claim_ids: c1, c2 - hash: `9fbc7bc759ef3382` ### s2 · pubmed · ok - title: Effect of Tesamorelin on Visceral Fat and Liver Fat in HIV - url: https://pubmed.ncbi.nlm.nih.gov/25038357/ - summary: Randomized trial demonstrating liver fat reduction. - quote: Tesamorelin significantly reduced visceral adipose tissue... and liver fat... net treatment effect of -2.9% in lipid to water percentage. - claim_ids: c3 - hash: `e9cea640fc0bbab3` ### s3 · reddit · ok - title: Tesamorelin Belly Fat Reduction - url: https://www.reddit.com/r/USPeptides/comments/1p3bh79/tesamorelin_belly_fat_reduction_growth_hormone/ - summary: User reports on visceral fat loss and rebound. - quote: It mainly reduces visceral fat via GH/IGF-1... the visceral fat lost on tesamorelin tends to come back pretty fast after stopping. - claim_ids: c5 - hash: `1de5f44cc0543d6c` ### s4 · x · ok - title: Tesamorelin note on X - url: https://x.com/peptigrity/status/2071503863547367680 - summary: X post summarizing trial reversal data. - quote: Two Phase 3 placebo-controlled trials in 800+ HIV patients showed a real reduction in visceral fat... the effect reversed when people stopped. - claim_ids: c6 - hash: `bfa509652e40bf54` ## Provenance (2 model passes) - chain valid: yes · head: `c883d0e210003477` - write · grok/grok-4.3 · 2026-06-29T23:20 · hash `fcdc1e467e0f` - voxel_divide · owner · 2026-07-17T02:42 · hash `c883d0e21000` ## Question graph - questions: 0 · evidence ingests: 0 ## LLM manifest — how to communicate with this ledger - system map: https://miscsubjects.com/api/articles/system-map?format=markdown - topology (ranked): https://miscsubjects.com/api/articles/tesamorelin-gut/topology - ingest: POST https://miscsubjects.com/api/protocol/ingest - claim: POST https://miscsubjects.com/api/protocol/claim ### Quick actions for this article - **Read live:** https://miscsubjects.com/api/articles/tesamorelin-gut/topology - **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"tesamorelin-gut","question":"..."}` - **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest tesamorelin-gut|your evidence` - **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim tesamorelin-gut|tier|assertion` - **iMessage ask:** `tesamorelin-gut|your question` - **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown --- ## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `system_map` — **System map** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **article slug:** `tesamorelin-gut` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **read:** https://miscsubjects.com/api/articles/system-map ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-gut/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest - **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip - **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip - **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tesamorelin-gut/bundle?format=markdown - **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.*